A detailed history of E Fund Management Co., Ltd. transactions in Catalent, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 3,319 shares of CTLT stock, worth $202,392. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,319
Holding current value
$202,392
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $186,395 - $202,326
3,319 New
3,319 $201,000
Q1 2021

May 12, 2021

BUY
$101.51 - $125.27 $123,639 - $152,578
1,218 New
1,218 $128,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.